Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 54.3% in February

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 6,900 shares, a decline of 54.3% from the February 13th total of 15,100 shares. Based on an average daily volume of 59,700 shares, the days-to-cover ratio is presently 0.1 days.

Ocean Biomedical Stock Performance

Shares of OCEAW traded down $0.00 during trading on Friday, reaching $0.02. The company’s stock had a trading volume of 5,500 shares, compared to its average volume of 41,446. Ocean Biomedical has a twelve month low of $0.02 and a twelve month high of $0.42. The company has a fifty day moving average of $0.03 and a two-hundred day moving average of $0.04.

Ocean Biomedical Company Profile

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.